A randomised double-blind placebo-controlled 10-way cross-over study shows that a new zolpidem modified-release formulation improves sleep maintenance compared to standard zolpidem

被引：0
|
作者：
Hindmarch, I [1 ]
Legangneux, E [1 ]
Stanley, N [1 ]
机构：
[1] Univ Surrey, HPRU Med Res Ctr, Guildford GU2 5XH, Surrey, England
来源：
SLEEP | 2004年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
123
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [1] A randomized double-blind placebo-controlled 10-way crossover study to show that a new zolpidem modified-release formulation improves sleep maintenance compared to standard zolpidem.
    Hindmarch, I
    Legangeux, E
    Emegbo, S
    Nixon, A
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P26 - P26
  • [2] A randomized double-blind placebo-controlled 3-way crossover study investigating psychomotor and cognitive residual effects of a new zolpidem modified-release formulation in healthy volunteers.
    Blin, O
    Micallef-Rolle, J
    Legangeux, E
    Zobouyan, I
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P27 - P27
  • [3] Zolpidem modified-release 12.5 mg improves measures of sleep continuity in a model of sleep disturbance (traffic noise) compared with standard zolpidem 10 mg.
    Stanley, N
    Hindmarch, I
    Legangeux, E
    Emegbo, S
    [J]. PHARMACOTHERAPY, 2005, 25 (10): : 1483 - 1483
  • [4] TREATMENT OF OSTEOARTHRITIS WITH A HERBOMINERAL FORMULATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY
    KULKARNI, RR
    PATKI, PS
    JOG, VP
    GANDAGE, SG
    PATWARDHAN, B
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 1991, 33 (1-2) : 91 - 95
  • [5] A randomized double-blind placebo-controlled 4-way crossover study investigating the residual psychomotor and cognitive effects of single oral doses of a new zolpidem modified-release formulation in healthy elderly volunteers.
    Hindmarch, I
    Legangeux, E
    Zobouyan, I
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P66 - P66
  • [6] Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study
    Cruse, Belinda
    Dharmadasa, Thanuja
    White, Elise
    Hollis, Callum
    Evans, Andrew
    Sharmin, Sifat
    Kalincik, Tomas
    Kiers, Lynette
    [J]. BMJ NEUROLOGY OPEN, 2022, 4 (02)
  • [7] Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
    Amiaz, Revital
    Fostick, Leah
    Gershon, Ari
    Zohar, Joseph
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (06) : 455 - 461
  • [8] Levosulpiride in somatoform disorders: A double-blind, placebo-controlled cross-over study
    Altamura, AC
    Di Rosa, A
    Ermentini, A
    Guaraldi, GP
    Invernizzi, G
    Rudas, N
    Tacchini, G
    Pioli, R
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (03) : 155 - 159
  • [9] Modified ketogenic diet in patients with McArdle disease: A double-blind, placebo-controlled, cross-over study
    Lokken, N.
    Nielsen, M.
    Stemmerik, M.
    Ellerton, C.
    Macrae, M.
    Revsbech, K.
    Krett, B.
    Beha, G.
    Quinlivan, R.
    Vissing, J.
    [J]. NEUROMUSCULAR DISORDERS, 2022, 32 : S73 - S73
  • [10] Rupatadine improves exposure time thresholds in patients with acquired cold urticaria: a randomised, double-blind, cross-over, placebo-controlled study
    Metz, M.
    Scholz, E.
    Izquierdo, I.
    Ferran, M.
    Torrents, A.
    Gimenez-Arnau, A.
    Maurer, M.
    [J]. ALLERGY, 2009, 64 : 518 - 518
12345